Qun Yang, co-founder of Biorbyt, and Christopher R. Lowe, from the University of Cambridge, talk about antibody testing and how the scientific community has risen to the challenge posed by Covid-19. Watch it here
1st September 2020
Siân Bolitho, Commercial Manager at Biorbyt, recently interviewed by Biocompare giving expert advice on optimizing immunoassay design and validation. Read more
24th August 2020
Biorbyt donates to Addenbrooke's
Biorbyt has recently donated 50 goggles and 50 coverall suits to Addenbrooke's Hospital.
14th July 2020
Read how Qun Yang, co-founder of Biorbyt, is accelerating the company's adapting action to overcome the challenges COVID-19 has presented. Read more
21st May 2020
Biorbyt on CGTN FRANÇAIS
A French news report on the importance of communication between Europe and China in the fight against CoVid-19. Biorbyt and other Cambridge start-ups are at the front line in helping the research on Coronavirus. Cambridge is world-renowned for its scientific excellence and Biorbyt are collaborating with Crayfish.io who offer a translating platform to facilitate the collaboration between China and the UK. This helps Biorbyt's provision of antibodies to research institutes around the world.
Qun Yang, co-founder of Biorbyt, says:
"The only way to get out of this crisis is by doing research in order to gain a better understanding of the virus."
1st May 2020
We have a useful array of products to help with your Coronavirus research.
Our range include primary antibodies and antigens, Small Molecules, ELISA Kits and Proteins for:
29st April 2020
Biorbyt on BBC Look East
Commercial Manager Siân Bolitho discusses Biorbyt's role in supplying antibodies for the Coronavirus outbreak. Ting Zhang from Crayfish discusses how her translation software enables a more efficient workflow for Biorbyt.
"We’ve started by using antibodies to very closely-related viruses...the SARS and the MERS from previous outbreaks...and we’ve looked at the sequences that were very quickly generated by Chinese scientists who sequenced the virus themselves, and they’re developing assays, they’re researching into how the virus mutates, how the virus is transmitted, and they’re looking to find a cure."
3rd March 2020